Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
NCT03208543
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
56
Enrollment
OTHER
Sponsor class
Stopped
failure rate 91.1%
Conditions
Cutaneous Leishmaniases
Interventions
DEVICE:
HECT-CL
Sponsor
Medecins Sans Frontieres, Netherlands